Diagnostic Accuracy of Ultrasound and 18-F-FDG PET or PET/CT for Patients with Suspected Recurrent Papillary Thyroid Carcinoma

Ultrasound in Medicine and Biology

Volumn 36, Issue 10, 2010, Pages 1608-1615

  Choi, Jin Woo ^a,b   Lee, Jeong Hyun ^a   Baek, Jung Hwan ^a   Choi, Byung Se ^a   Jeong, Kyung Soon ^a   Ryu, Jin Sook ^a   Kim, Tae Yong ^a   Kim, Won Bae ^a   Shong, Young Kee ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Metastasis; Positron emission tomography; Recurrence; Thyroid cancer; Ultrasound

Indexed keywords

METASTASIS; POSITRON EMISSION; RECURRENCE; THYROID CANCERS; ULTRASOUND;

COMPUTERIZED TOMOGRAPHY; ELECTRONS; IODINE; PATHOLOGY; PLATINUM COMPOUNDS; POSITRONS; ULTRASONICS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; RADIOACTIVE IODINE; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR; YOUNG ADULT;

EID: 77956641470     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2010.07.013     Document Type: Article

References (32)

1. Alzahrani A.S., Alsuhaibani H., Salam S.A., Al Sifri S.N., Mohamed G., Al Sobhi S., Sulaiman O., Akhtar M. Diagnostic accuracy of high-resolution neck ultrasonography in the follow-up of differentiated thyroid cancer: A prospective study. Endocr Pract 2005, 11:165-171.
2. Antonelli A., Miccoli P., Fallahi P., Grosso M., Nesti C., Spinelli C., Ferrannini E. Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid 2003, 13:479-484.
3. Cohen E.G., Tuttle R.M., Kraus D.H. Postoperative management of differentiated thyroid cancer. Otolaryngol Clin North Am 2003, 36:129-157.
4. de Groot J.W., Plukker J.T., Wolffenbuttel B.H., Wiggers T., Sluiter W.J., Links T.P. Determinants of life expectancy in medullary thyroid cancer: Age does not matter. Clin Endocrinol (Oxf) 2006, 65:729-736.
5. do Rosario P.W., Fagundes T.A., Maia F.F., Franco A.C., Figueiredo M.B., Purisch S. Sonography in the diagnosis of cervical recurrence in patients with differentiated thyroid carcinoma. J Ultrasound Med 2004, 23:915-920. quiz 21-22.
6. Eustatia-Rutten C.F.A., Smit J.W.A., Romijn J.A., Kleij-Corssmit EPMvd, Pereira A.M., Stokkel M.P., Kievit J. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clinical Endocrinol 2004, 61:61-74.
7. Frasoldati A., Pesenti M., Gallo M., Caroggio A., Salvo D., Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003, 97:90-96.
8. Frilling A., Gorges R., Tecklenborg K., Gassmann P., Bockhorn M., Clausen M., Broelsch C.E. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 2000, 128:1067-1074.
9. Goshen E., Cohen O., Rotenberg G., Oksman Y., Karasik A., Zwas S.T. The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma. Nucl Med Commun 2003, 24:959-961.
10. Haber R.S. Role of ultrasonography in the diagnosis and management of thyroid cancer. Endocr Pract 2000, 6:396-400.
11. Khan N., Oriuchi N., Higuchi T., Zhang H., Endo K. PET in the follow-up of differentiated thyroid cancer. Br J Radiol 2003, 76:690-695.
12. Kim J.H., Lee J.H., Shong Y.K., Hong S.J., Ko M.-S., Lee D.H., Choi C.G., Kim S.J. Ultrasound features of suture granulomas in the thyroid bed after thyroidectomy for papillary thyroid carcinoma with an emphasis on their differentiation from locally recurrent thyroid carcinomas. Ultrasound Med Biol 2009, 35:1452-1457.
13. Ko M.-S., Lee J.H., Shong Y.K., Gong G.Y., Baek J.H. Normal and abnormal sonographic findings at the thyroidectomy sites in postoperative patients with thyroid malignancy. Am J Roentgenol 2010, 194:1596-1609.
14. Kuna S.K., Bracic I., Tesic V., Kuna K., Herceg G.H., Dodig D. Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 2006, 25:1531-1537. quiz 8-40.
15. Leboulleux S., Girard E., Rose M., Travagli J.P., Sabbah N., Caillou B., Hartl D.M., Lassau N., Baudin E., Schlumberger M. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007, 92:3590-3594.
16. Leboulleux S., Schroeder P.R., Schlumberger M., Ladenson P.W. The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers. Nat Clin Pract Endocrinol Metab 2007, 3:112-121.
17. Lee J.H., Lee H.K., Lee D.H., Choi C.G., Gong G., Shong Y.K., Kim S.J. Ultrasonographic findings of a newly detected nodule on the thyroid bed in postoperative patients for thyroid carcinoma: Correlation with the results of ultrasonography-guided fine-needle aspiration biopsy. Clin Imaging 2007, 31:109-113.
18. Lee Y.H., Lee N.J., Kim J.H., Song J.J. US diagnosis of cervical recurrence in patients operated on thyroid cancer: Sonographic features and clinical significance. Auris Nasus Larynx 2007, 34:213-219.
19. Lind P., Kohlfurst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med 2006, 36:194-205.
20. Ma C., Kuang A., Xie J., Ma T. Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning. J Nucl Med 2005, 46:1473-1480.
21. Nanni C., Rubello D., Fanti S., Farsad M., Ambrosini V., Rampin L., Banti E., Carpi A., Muzzio P., Franchi R. Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer. Biomed Pharmacother 2006, 60:409-413.
22. Pacini F., Molinaro E., Castagna M.G., Agate L., Elisei R., Ceccarelli C., Lippi F., Taddei D., Grasso L., Pinchera A. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003, 88:3668-3673.
23. Palmedo H., Bucerius J., Joe A., Strunk H., Hortling N., Meyka S., Roedel R., Wolff M., Wardelmann E., Biersack H.J., Jaeger U. Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med 2006, 47:616-624.
24. Rosario P.W.S., de Faria S., Bicalho L., Alves M.F.G., Borges M.A.R., Purisch S., Padrao E.L., Rezende L.L., Barroso A.L. Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med 2005, 24:1385-1389.
25. Schlumberger M., Mancusi F., Baudin E., Pacini F. 131I therapy for elevated thyroglobulin levels. Thyroid 1997, 7:273-276.
26. Schlumberger M.J. Papillary and follicular thyroid carcinoma. N Engl J Med 1998, 338:297-306.
27. Shammas A., Degirmenci B., Mountz J.M., McCook B.M., Branstetter B., Bencherif B., Joyce J.M., Carty S.E., Kuffner H.A., Avril N. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med 2007, 48:221-226.
28. Sherman S.I., Angelos P., Ball D.W., Byrd D., Clark O.H., Daniels G.H., Dilawari R.A., Ehya H., Farrar W.B., Gagel R.F., Kandeel F., Kloos R.T., Kopp P., Lamonica D.M., Loree T.R., Lydiatt W.M., McCaffrey J., Olson J.A., Ridge J.A., Shah J.P., Sisson J.C., Tuttle R.M., Urist M.M. Thyroid carcinoma. J Natl Compr Canc Netw 2007, 5:568-621.
29. Shreve P.D., Anzai Y., Wahl R.L. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics 1999, 19:61-77. quiz 150-151.
30. Stokkel M.P., Duchateau C.S., Dragoiescu C. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging 2006, 50:78-87.
31. Yeo J.S., Chung J.K., So Y., Kim S., Lee E., Lee D.S., Youn Y.K., Hong S.J., Ahn I.M., Lee M.C., Cho B.Y. F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes. Head Neck 2001, 23:94-103.
32. Zimmer L.A., McCook B., Meltzer C., Fukui M., Bascom D., Snyderman C., Townsend D.W., Johnson J.T. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer. Otolaryngol Head Neck Surg 2003, 128:178-184.